231 related articles for article (PubMed ID: 11071270)
1. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays.
Martoglio AM; Tom BD; Starkey M; Corps AN; Charnock-Jones DS; Smith SK
Mol Med; 2000 Sep; 6(9):750-65. PubMed ID: 11071270
[TBL] [Abstract][Full Text] [Related]
2. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
Welsh JB; Zarrinkar PP; Sapinoso LM; Kern SG; Behling CA; Monk BJ; Lockhart DJ; Burger RA; Hampton GM
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1176-81. PubMed ID: 11158614
[TBL] [Abstract][Full Text] [Related]
3. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
[TBL] [Abstract][Full Text] [Related]
5. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.
Schummer M; Ng WV; Bumgarner RE; Nelson PS; Schummer B; Bednarski DW; Hassell L; Baldwin RL; Karlan BY; Hood L
Gene; 1999 Oct; 238(2):375-85. PubMed ID: 10570965
[TBL] [Abstract][Full Text] [Related]
6. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.
Vecchione A; Belletti B; Lovat F; Volinia S; Chiappetta G; Giglio S; Sonego M; Cirombella R; Onesti EC; Pellegrini P; Califano D; Pignata S; Losito S; Canzonieri V; Sorio R; Alder H; Wernicke D; Stoppacciaro A; Baldassarre G; Croce CM
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9845-50. PubMed ID: 23697367
[TBL] [Abstract][Full Text] [Related]
7. Profiling of selected angiogenesis-related genes in serous ovarian cancer patients.
Kuć P; Charkiewicz R; Klasa-Mazurkiewicz D; Milczek T; Mroczko B; Nikliński J; Laudański P
Adv Med Sci; 2017 Mar; 62(1):116-120. PubMed ID: 28235714
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of alternative probe synthesis approaches for gene expression profiling with arrays.
Vernon SD; Unger ER; Rajeevan M; Dimulescu IM; Nisenbaum R; Campbell CE
J Mol Diagn; 2000 Aug; 2(3):124-7. PubMed ID: 11229515
[TBL] [Abstract][Full Text] [Related]
9. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.
Sawiris GP; Sherman-Baust CA; Becker KG; Cheadle C; Teichberg D; Morin PJ
Cancer Res; 2002 May; 62(10):2923-8. PubMed ID: 12019173
[TBL] [Abstract][Full Text] [Related]
10. Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array.
Chen KT; Lin JD; Chao TC; Hsueh C; Chang CA; Weng HF; Chan EC
Thyroid; 2001 Jan; 11(1):41-6. PubMed ID: 11272096
[TBL] [Abstract][Full Text] [Related]
11. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.
Yoneda J; Kuniyasu H; Crispens MA; Price JE; Bucana CD; Fidler IJ
J Natl Cancer Inst; 1998 Mar; 90(6):447-54. PubMed ID: 9521169
[TBL] [Abstract][Full Text] [Related]
12. Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes.
Mendiola M; Redondo A; Heredia-Soto V; Herranz J; Berjón A; Hernández A; Miguel-Martín M; Crespo R; Barriuso J; Cruz P; Yébenes L; Peláez-García A; Castelo B; DE Molina AR; Feliu J; Hardisson D
Anticancer Res; 2018 Sep; 38(9):5393-5400. PubMed ID: 30194194
[TBL] [Abstract][Full Text] [Related]
13. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis.
Chaib H; Cockrell EK; Rubin MA; Macoska JA
Neoplasia; 2001; 3(1):43-52. PubMed ID: 11326315
[TBL] [Abstract][Full Text] [Related]
14. Changes in gene expression during progression of ovarian carcinoma.
Tapper J; Kettunen E; El-Rifai W; Seppälä M; Andersson LC; Knuutila S
Cancer Genet Cytogenet; 2001 Jul; 128(1):1-6. PubMed ID: 11454421
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.
Jazaeri AA; Yee CJ; Sotiriou C; Brantley KR; Boyd J; Liu ET
J Natl Cancer Inst; 2002 Jul; 94(13):990-1000. PubMed ID: 12096084
[TBL] [Abstract][Full Text] [Related]
16. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
Birrer MJ; Johnson ME; Hao K; Wong KK; Park DC; Bell A; Welch WR; Berkowitz RS; Mok SC
J Clin Oncol; 2007 Jun; 25(16):2281-7. PubMed ID: 17538174
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
[TBL] [Abstract][Full Text] [Related]
18. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
19. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
20. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
